We encourage companies
that project change
that project change
- RT @infoCaixa: #MedLumics, compañía participada por @CaixaCR e @YsiosCapital, cierra una ronda de financiación de 34,4 M€ https://t.co/tSyu…
- RT @ctrenchs: Medlumics cierra la mayor ronda de inversión del sector de las tecnologías médicas en España @CaixaCR @YsiosCapital https://t…
- RT @ctrenchs: Convocatoria abierta tercera edición https://t.co/g9WFpV6CxK. Muy orgulloso iniciativa conjunta @CaixaCR y @FundlaCaixa en Te…
News & events
MedLumics, a company owned by "la Caixa" and Ysios Capital, closes a financing round of 34.4 million euros
• Medlumics has closed a round of financing round of 34,4 million euros to bring their main product into the market, AblaView, an atrial fibrillation treatment in the field of cardiac arrhythmias. • Medlumics is a company dedicated to medical technology for the treatment of cardiac diseases, with products based on photonic energy. • Caixa Capital Risc and Ysios Capital invested in Medlumics in 2012 to support the company in its development. • This has been the largest round in the history of the medical technology industry in Spain, and one of the largest in Europe.
Other news See all news »
SUMMUS RENDER reinforces its plans for the future with a 1.600.000€ investment from Inveready Technology Investment Group and Caixa Capital Risc
06.02.2017• Summus Render is a tech company based in Madrid, specialising in mass computer processing. Its main business focus is 3D rendering for animation, architecture...
03.02.2017Caixa Capital Risc and Kereon Partners invest in spin-off created from IDIBAPS-Hospital ...
The “la Caixa” Foundation and “Caixa Capital Risc” open calls for applications for the CaixaImpulse program to promote the creation of new biotechnological engineering companies.
31.01.2017EIT Health, leading European consortium for innovation in biomedicine, collaborates in this edition of the pioneering program. engineering companies. • To...